[Experimental basis for using physical and enzyme therapy with terrilytin in renal tuberculosis].
Bellendir
E N
EN
Iagafarova
R K
RK
D000681:Amylases / Q000627:therapeutic use*; D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D007478:Iontophoresis; D007668:Kidney / Q000473:pathology; D008297:Male; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D011817:Rabbits; D013997:Time Factors; D014398:Tuberculosis, Renal / Q000473:pathology / Q000628:therapy*; D014464:Ultrasonic Therapy
D000995:Antitubercular Agents; D004338:Drug Combinations; C009402:amylase, phosphates, proteases drug combinations; D000681:Amylases; D010447:Peptide Hydrolases
Eksperimental'noe obosnovanie primeneniia fizioénzimoterapii s terrilitinom pri tuberkuleze pochek.